A patient with suspected cardiogenic shock and SpO2 of 88% should receive which oxygen therapy?

A patient with suspected cardiogenic shock and SpO2 of 88% should receive which oxygen therapy?

• A. As needed, nasal cannula oxygen
• B. Nonrebreather mask at high flow
• C. Venturi mask set to 50%
• D. Bag-valve mask with 100% oxygen

Answer: (A)

The main idea is to correct low oxygen saturation in a patient with suspected cardiogenic shock using the least invasive method that still allows you to fine-tune how much oxygen is delivered. A nasal cannula provides supplemental oxygen in a titratable, comfortable way, so you can start oxygen and adjust how much you give based on the patient’s SpO2. This keeps oxygen delivery controlled and minimizes potential negative effects of more aggressive airway support on the patient’s hemodynamics. If the SpO2 remains low after starting nasal oxygen, you would escalate to a higher‑FiO2 device to push the oxygen level up more quickly. Higher‑FiO2 options deliver more oxygen but also introduce more potential issues in shock, such as increased airway pressures or discomfort, so they’re used when the target SpO2 isn’t reached with a nasal cannula.

The main idea is to correct low oxygen saturation in a patient with suspected cardiogenic shock using the least invasive method that still allows you to fine-tune how much oxygen is delivered. A nasal cannula provides supplemental oxygen in a titratable, comfortable way, so you can start oxygen and adjust how much you give based on the patient’s SpO2. This keeps oxygen delivery controlled and minimizes potential negative effects of more aggressive airway support on the patient’s hemodynamics.

If the SpO2 remains low after starting nasal oxygen, you would escalate to a higher‑FiO2 device to push the oxygen level up more quickly. Higher‑FiO2 options deliver more oxygen but also introduce more potential issues in shock, such as increased airway pressures or discomfort, so they’re used when the target SpO2 isn’t reached with a nasal cannula.